Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy

View source ↗

Summary

An update on a compassionate-use program evaluating brivaracetam for patients with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Epilepsy | Status: AVAILABLE